1. Newly Approved and Investigational Drugs for Motor Symptom Control in Parkinson's Disease

   • Daniel Garbin Di Luca
   • Nikolai Gil D. Reyes
   • Susan H. Fox

   Leading Article 16 July 2022 Pages: 1027 - 1053

   

2. Potential Therapeutic Agents That Target ATP Binding Cassette A1 (ABCA1) Gene Expression

   • Michael J. Haas
   • Arshag D. Mooradian

   Review Article 21 July 2022 Pages: 1055 - 1075

   

3. Improving Treatment Options for Primary Hyperoxaluria

   • Bernd Hoppe
   • Cristina Martin-Higueras

   Review Article Open access 02 July 2022 Pages: 1077 - 1094

   

4. Drugs in Clinical Development to Treat Autosomal Dominant Polycystic Kidney Disease

   • Thomas Bais
   • Ron T. Gansevoort
   • Esther Meijer

   Review Article Open access 19 July 2022 Pages: 1095 - 1115

   

5. Estetrol/Drospirenone: A Review in Oral Contraception

   • Arnold Lee
   • Yahiya Y. Syed

   Adis Drug Evaluation Open access 04 July 2022 Pages: 1117 - 1125

   

6. Mavacamten: First Approval

   • Susan J. Keam

   AdisInsight Report Open access 08 July 2022 Pages: 1127 - 1135

   

7. Serplulimab: First Approval

   • Arnold Lee

   AdisInsight Report 07 July 2022 Pages: 1137 - 1141

   

8. Nemolizumab: First Approval

   • Susan J. Keam

   AdisInsight Report 14 July 2022 Pages: 1143 - 1150